Piedmont Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-15,742
| Closed | -$1.33M | – | 89 |
|
|
2020
Q1 | $1.33M | Buy |
15,742
+2,277
| +17% | +$192K | 0.05% | 261 |
|
|
2019
Q4 | $1.14M | Buy |
13,465
+103
| +0.8% | +$8.71K | 0.04% | 309 |
|
|
2019
Q3 | $901K | Buy |
13,362
+123
| +0.9% | +$8.29K | 0.03% | 346 |
|
|
2019
Q2 | $1.13M | Buy |
13,239
+349
| +3% | +$29.9K | 0.05% | 299 |
|
|
2019
Q1 | $1.15M | Buy |
12,890
+60
| +0.5% | +$5.33K | 0.05% | 270 |
|
|
2018
Q4 | $1.09M | Buy |
12,830
+49
| +0.4% | +$4.17K | 0.05% | 257 |
|
|
2018
Q3 | $1.24M | Buy |
12,781
+8,932
| +232% | +$866K | 0.05% | 266 |
|
|
2018
Q2 | $363K | Sell |
3,849
-2,183
| -36% | -$206K | 0.02% | 552 |
|
|
2018
Q1 | $489K | Hold |
6,032
| – | – | 0.01% | 421 |
|
|
2017
Q4 | $538K | Hold |
6,032
| – | – | 0.01% | 396 |
|
|
2017
Q3 | $561K | Buy |
+6,032
| New | +$561K | 0.01% | 391 |
|